122 related articles for article (PubMed ID: 2075377)
1. Cryptogenic chronic active liver disease. Evaluation of serum aminoterminal peptide of type III procollagen as a marker of histological activity.
Diodati G; Bonetti P; Plebani M; Giacomini A; Rugge M; Realdi G; Burlina A
Ric Clin Lab; 1990; 20(4):253-9. PubMed ID: 2075377
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of aminoterminal type III procollagen peptide in normal subjects and hepatic fibrosis.
Nakano H; Nakabayashi H; Okamoto Y; Kawasaki T; Seko S; Fukuda Y
Gastroenterol Jpn; 1985 Dec; 20(6):573-6. PubMed ID: 4085749
[TBL] [Abstract][Full Text] [Related]
3. Serum type I collagen and N-terminal peptide of type III procollagen in chronic hepatitis. Relationship to liver histology and conventional liver tests.
Trinchet JC; Hartmann DJ; Pateron D; Laarif M; Callard P; Ville G; Beaugrand M
J Hepatol; 1991 Mar; 12(2):139-44. PubMed ID: 1711064
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of serum laminin P1, procollagen-III peptides, and N-acetyl-beta-glucosaminidase for monitoring the activity of liver fibrosis.
Schneider M; Voss B; Högemann B; Eberhardt G; Gerlach U
Hepatogastroenterology; 1989 Dec; 36(6):506-10. PubMed ID: 2693303
[TBL] [Abstract][Full Text] [Related]
5. [Procollagen III and laminin in chronic viral hepatopathies].
Montalto G; Soresi M; Aragona F; Tripi S; Carroccio A; Anastasi G; Magliarisi C; Barresi E; Notarbartolo A
Presse Med; 1996 Jan; 25(2):59-62. PubMed ID: 8745719
[TBL] [Abstract][Full Text] [Related]
6. Serum laminin and type III procollagen in chronic hepatitis C. Diagnostic value in the assessment of disease activity and fibrosis.
Gabrielli GB; Capra F; Casaril M; Squarzoni S; Tognella P; Dagradi R; De Maria E; Colombari R; Corrocher R; De Sandre G
Clin Chim Acta; 1997 Sep; 265(1):21-31. PubMed ID: 9352126
[TBL] [Abstract][Full Text] [Related]
7. Serum type III procollagen peptide concentrations in severe chronic active hepatitis: relationship to cirrhosis and disease activity.
McCullough AJ; Stassen WN; Wiesner RH; Czaja AJ
Hepatology; 1987; 7(1):49-54. PubMed ID: 3492417
[TBL] [Abstract][Full Text] [Related]
8. Serum type III procollagen peptide, type IV collagen 7S domain, central triple-helix of type IV collagen and tissue inhibitor of metalloproteinases in patients with chronic viral liver disease: relationship to liver histology.
Murawaki Y; Ikuta Y; Koda M; Kawasaki H
Hepatology; 1994 Oct; 20(4 Pt 1):780-7. PubMed ID: 7927217
[TBL] [Abstract][Full Text] [Related]
9. Serum hyaluronate and type III procollagen aminoterminal propeptide concentration in chronic liver disease. Relationship to cirrhosis and disease activity.
Ramadori G; Zöhrens G; Manns M; Rieder H; Dienes HP; Hess G; Meyer KH; Büschenfelde Z
Eur J Clin Invest; 1991 Jun; 21(3):323-30. PubMed ID: 1909636
[TBL] [Abstract][Full Text] [Related]
10. [Determination of serum procollagen-III peptide in chronic liver diseases. Clinical usefulness].
Pagani A; Zigliani P; Pranzo A; Galante T
Minerva Med; 1992 Nov; 83(11):715-20. PubMed ID: 1461542
[TBL] [Abstract][Full Text] [Related]
11. Is determination of serum N-terminal procollagen type III peptide (sPIIIP) a marker of hepatic fibrosis?
Surrenti C; Casini A; Milani S; Ambu S; Ceccatelli P; D'Agata A
Dig Dis Sci; 1987 Jul; 32(7):705-9. PubMed ID: 3595382
[TBL] [Abstract][Full Text] [Related]
12. Basement membrane-related and type III procollagen-related antigens in serum of patients with chronic viral liver disease.
Misaki M; Shima T; Yano Y; Sumita Y; Kano U; Murata T; Watanabe S; Suzuki S
Clin Chem; 1990 Mar; 36(3):522-4. PubMed ID: 2311224
[TBL] [Abstract][Full Text] [Related]
13. Aminoterminal propeptide of type III procollagen: a marker of disease activity in schistosomal patients.
Fayol V; Hassanein HI; el-Badrawy N; Ville G; Hartmann DJ
Eur J Clin Chem Clin Biochem; 1991 Nov; 29(11):737-41. PubMed ID: 1782280
[TBL] [Abstract][Full Text] [Related]
14. Steroid treatment lowers hepatic fibroplasia, as explored by serum aminoterminal procollagen III peptide, in chronic liver disease.
Ballardini G; Faccani A; Bianchi FB; Fallani M; Patrono D; Capelli M; Pisi E
Liver; 1984 Dec; 4(6):348-52. PubMed ID: 6521615
[TBL] [Abstract][Full Text] [Related]
15. [Serum determination of N-terminal peptide of type III procollagen as a marker of fibrotic activity].
García Montes JM; De Bonilla Blánez F; Herrerías Gutiérrez JM
Rev Esp Enferm Apar Dig; 1989 Mar; 75(3):241-5. PubMed ID: 2734469
[TBL] [Abstract][Full Text] [Related]
16. Procollagen-III peptide and chronic viral C hepatitis.
Jeffers LJ; Coelho-Little ME; Cheinquer H; Vargas C; Civantos F; Alvarez L; Reddy KR; Parker T; de Medina M; Li X
Am J Gastroenterol; 1995 Sep; 90(9):1437-40. PubMed ID: 7661165
[TBL] [Abstract][Full Text] [Related]
17. Liver stellate cells and aminoterminal peptide of type III procollagen in chronic hepatitis C treated with interferon.
Gabrielli GB; Casaril M; Stanzial AM; Colombari R; Pasino M; Corrocher R
Hepatogastroenterology; 2003; 50(54):2017-21. PubMed ID: 14696456
[TBL] [Abstract][Full Text] [Related]
18. [Predictive value of serum aminoterminal type III procollagen peptide levels, serum laminin levels, and liver membrane antibodies for prognosis of chronic hepatitis].
Hirata R
Nihon Shokakibyo Gakkai Zasshi; 1989 Apr; 86(4):905-12. PubMed ID: 2754842
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic accuracy of hyaluronan and type III procollagen amino-terminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis C evaluated by ROC curve analysis.
Guéchot J; Laudat A; Loria A; Serfaty L; Poupon R; Giboudeau J
Clin Chem; 1996 Apr; 42(4):558-63. PubMed ID: 8605673
[TBL] [Abstract][Full Text] [Related]
20. Serum procollagen type III peptide in chronic hepatitis B. Relationship to disease activity and response to interferon-alpha therapy.
Giustina G; Fattovich G; De Paoli M; Guido M; Favarato S; Rugge M; Alberti A; Ruol A; Plebani M
Int J Clin Lab Res; 1996; 26(1):33-6. PubMed ID: 8739853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
